1. Home
  2. FNWB vs CTMX Comparison

FNWB vs CTMX Comparison

Compare FNWB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • CTMX
  • Stock Information
  • Founded
  • FNWB 1923
  • CTMX 2008
  • Country
  • FNWB United States
  • CTMX United States
  • Employees
  • FNWB N/A
  • CTMX N/A
  • Industry
  • FNWB Banks
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • CTMX Health Care
  • Exchange
  • FNWB Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • FNWB 79.5M
  • CTMX 444.3M
  • IPO Year
  • FNWB 2015
  • CTMX 2015
  • Fundamental
  • Price
  • FNWB $8.13
  • CTMX $2.41
  • Analyst Decision
  • FNWB Hold
  • CTMX Strong Buy
  • Analyst Count
  • FNWB 1
  • CTMX 2
  • Target Price
  • FNWB $12.00
  • CTMX $5.00
  • AVG Volume (30 Days)
  • FNWB 50.2K
  • CTMX 2.6M
  • Earning Date
  • FNWB 07-24-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • FNWB 3.44%
  • CTMX N/A
  • EPS Growth
  • FNWB N/A
  • CTMX 128.27
  • EPS
  • FNWB N/A
  • CTMX 0.49
  • Revenue
  • FNWB $45,593,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • FNWB $38.07
  • CTMX N/A
  • Revenue Next Year
  • FNWB $13.43
  • CTMX N/A
  • P/E Ratio
  • FNWB N/A
  • CTMX $5.15
  • Revenue Growth
  • FNWB N/A
  • CTMX 23.81
  • 52 Week Low
  • FNWB $6.05
  • CTMX $0.40
  • 52 Week High
  • FNWB $12.10
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 48.31
  • CTMX 57.13
  • Support Level
  • FNWB $6.05
  • CTMX $2.15
  • Resistance Level
  • FNWB $8.89
  • CTMX $2.44
  • Average True Range (ATR)
  • FNWB 0.53
  • CTMX 0.22
  • MACD
  • FNWB 0.10
  • CTMX -0.03
  • Stochastic Oscillator
  • FNWB 73.24
  • CTMX 41.67

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: